摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

{Cu(1,6-bis(3,5-dimethyl-1-pyrazolyl)-2,5-dithiahexane)(dinitrate)} | 137425-74-2

中文名称
——
中文别名
——
英文名称
{Cu(1,6-bis(3,5-dimethyl-1-pyrazolyl)-2,5-dithiahexane)(dinitrate)}
英文别名
——
{Cu(1,6-bis(3,5-dimethyl-1-pyrazolyl)-2,5-dithiahexane)(dinitrate)}化学式
CAS
137425-74-2
化学式
C14H22CuN6O6S2
mdl
——
分子量
498.043
InChiKey
FIVFMMZKISXDHG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为产物:
    参考文献:
    名称:
    Copper coordination compounds of the ligand 1,6-bis(3,5-dimethyl-1-pyrazolyl)-2,5-dithiahexane (bddh). X-ray structures of [Cu(bddh)]2(BF4)2, [Cu(bddh)Cl]2CuCl4 and [Cu(bddh)(3,5-dimethylpyrazole)](BF4)2
    摘要:
    The new ligand 1,6-bis(3,5-dimethyl-1-pyrazolyl)-2,5-dithiahexane (bddh) rendered the following coordination compounds with copper(I) and copper(II) salts: Cu(bddh)(NO3)2, [Cu(bddh)(H2O)](BF4)2, [Cu(bddh)Cl]2CuCl4, [Cu(bddh)(Hdmpz)](BF4)2 (Hdmpz = 3,5-dimethylpyrazole), [Cu(bddh)Cl]BF4, [Cu(bddh)]2(BF4)2, Cu(bddh)Cl and Cu(bddh)Br. The compound [Cu(bddh)Cl]2CuCl4 crystallizes from ethanol in the monoclinic space group Cc, with a = 19.018(4), b = 14.840(3), c = 14.963(3) angstrom, beta = 100.24(2), V = 4158 angstrom 3, Z = 4 and D(calc) = 1.63 g cm-3. The refinement using 5145 measured and 1826 observed (F > 2-sigma(F) reflections resulted in the R values 0.062 (R) and 0.068 (R(w)). The asymmetric unit consists of two [Cu(bddh)Cl]+ cations and a CuCl4(2-) anion. The copper(II) atom in [Cu(bddh)Cl]+ cation is coordinated by two pyrazole nitrogen atoms in trans position (1.991(9) and 1.98(1) angstrom), two thioether atoms in cis position (2.422(3) and 2.480(3) angstrom) and one chloride atom (2.249(4) angstrom) in a distorted trigonal bipyramid with the nitrogen donors on axial positions and the two sulfurs and chloride in the equatorial plane. The tetrahedral CuCl4(2-) anion lies in disorder. The compound [Cu(bddh)(Hdmpz)](BF4)2 crystallizes from ethanol in the monoclinic space group P2(1)/c, with a = 18.360(3), b = 9.419(3), c = 16.068(2) angstrom, beta = 100.29(1), V = 2734 angstrom 3, Z = 4 and D(calc) = 1.55 g cm-3. The refinement using 6883 measured and 2326 observed (F > 2-sigma(F)) reflections resulted in the R values 0.55 (R) and 0.061 (R(w)). The asymmetric unit consists of a [Cu(bddh)(Hdmpz)]2+ cation and two tetrafluoroborate anions. The copper(II) atom is coordinated by three pyrazole nitrogen atoms (1.987(6) and 1.962(6) angstrom; Hdmpz: 1.977(6) angstrom) and two sulfur atoms (2.478(2) and 2.404(3) angstrom) in a distorted trigonal bipyramid, with the ligand pyrazole groups on axial positions. The copper(I) compound [Cu(bddh)]2(BF4)2 crystallizes from ethanol in the monoclinic space group C2/c, with a = 22.679(2), b = 12.766(2), c = 14.213(2) angstrom, beta = 106.69(1), V = 3942 angstrom 3, Z = 8 and D(calc) = 1.55 g cm-3. The refinement using 1495 observed (F > 2.5-sigma(F)) reflections resulted in the R values 0.049 (R) and 0.082 (R(w)). The cationic part of the compound is dinuclear with C2 symmetry. The copper(I) ions are 4.603(3) angstrom apart. Each copper(I) ion is coordinated by a pyrazole nitrogen atom at 2.067(6) angstrom and two thioether atoms at 2.426(2) and 2.333(3) angstrom from one ligand and by a pyrazole nitrogen at 1.980(8) angstrom of another ligand in a strongly distorted tetrahedral fashion. Spectroscopic results strongly suggest that the compounds [Cu(bddh)(H2O)](BF4)2 and [Cu(bddh)Cl]BF4 contain the trigonal bipyramidal [Cu(bddh)A] unit (A = anion), as present in [Cu(bddh)Cl]2CuCl4 and [Cu(bddh)(Hdmpz)](BF4)2. The compounds Cu(bddh)Cl and Cu(bddh)Br are IR and X-ray isomorphous.
    DOI:
    10.1016/s0020-1693(00)85424-9
点击查看最新优质反应信息

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫